These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 26120520
1. Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects. Shamizadeh S, Brockow K, Ring J. Allergo J Int; 2014; 23(3):87-95. PubMed ID: 26120520 [Abstract] [Full Text] [Related]
2. Rupatadine: global safety evaluation in allergic rhinitis and urticaria. González-Núñez V, Bachert C, Mullol J. Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993 [Abstract] [Full Text] [Related]
3. Rupatadine in allergic rhinitis and chronic urticaria. Mullol J, Bousquet J, Bachert C, Canonica WG, Gimenez-Arnau A, Kowalski ML, Martí-Guadaño E, Maurer M, Picado C, Scadding G, Van Cauwenberge P. Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040 [Abstract] [Full Text] [Related]
4. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Izquierdo I, Merlos M, García-Rafanell J. Drugs Today (Barc); 2003 Jun; 39(6):451-68. PubMed ID: 12944997 [Abstract] [Full Text] [Related]
5. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. Katiyar S, Prakash S. Prim Care Respir J; 2009 Jun; 18(2):57-68. PubMed ID: 18695846 [Abstract] [Full Text] [Related]
6. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years. Potter P, Mitha E, Barkai L, Mezei G, Santamaría E, Izquierdo I, Maurer M. Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219 [Abstract] [Full Text] [Related]
7. Update on rupatadine in the management of allergic disorders. Mullol J, Bousquet J, Bachert C, Canonica GW, Giménez-Arnau A, Kowalski ML, Simons FE, Maurer M, Ryan D, Scadding G. Allergy; 2015 Jan; 70 Suppl 100():1-24. PubMed ID: 25491409 [Abstract] [Full Text] [Related]
8. Rupatadine: a review of its use in the management of allergic disorders. Keam SJ, Plosker GL. Drugs; 2007 Jan; 67(3):457-74. PubMed ID: 17335300 [Abstract] [Full Text] [Related]
9. The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine. Nieto A, Nieto M, Mazón Á. Expert Opin Pharmacother; 2021 Mar; 22(4):511-519. PubMed ID: 33198523 [Abstract] [Full Text] [Related]
10. Rupatadine: pharmacological profile and its use in the treatment of allergic disorders. Picado C. Expert Opin Pharmacother; 2006 Oct; 7(14):1989-2001. PubMed ID: 17020424 [Abstract] [Full Text] [Related]
11. Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis. Sudhakara Rao M, Dwarakanatha Reddy D, Murthy PS. Indian J Otolaryngol Head Neck Surg; 2009 Dec; 61(4):320-32. PubMed ID: 23120659 [Abstract] [Full Text] [Related]
12. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study. Potter P, Maspero JF, Vermeulen J, Barkai L, Németh I, Baillieau RA, Garde JM, Giralt J, Doménech A, Izquierdo I, Nieto A. Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091 [Abstract] [Full Text] [Related]
13. Rupatadine for the treatment of urticaria. Nettis E, Delle Donne P, Di Leo E, Calogiuri GF, Ferrannini A, Vacca A. Expert Opin Pharmacother; 2013 Sep; 14(13):1807-13. PubMed ID: 23806068 [Abstract] [Full Text] [Related]
14. How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review. Izquierdo I, Casas L, Cabrera S, Fernandez A. Drugs Context; 2024 Sep; 13():. PubMed ID: 38264404 [Abstract] [Full Text] [Related]
15. Rupatadine for the treatment of allergic rhinitis and urticaria. Metz M, Maurer M. Expert Rev Clin Immunol; 2011 Jan; 7(1):15-20. PubMed ID: 21162645 [Abstract] [Full Text] [Related]
16. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial. Okubo K, Suzuki T, Tanaka A, Aoki H. Allergol Int; 2019 Apr; 68(2):207-215. PubMed ID: 30391169 [Abstract] [Full Text] [Related]
17. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). Munoz-Cano R, Ainsua-Enrich E, Torres-Atencio I, Martin M, Sánchez-Lopez J, Bartra J, Picado C, Mullol J, Valero A. J Investig Allergol Clin Immunol; 2017 Apr; 27(3):161-168. PubMed ID: 27758758 [Abstract] [Full Text] [Related]
18. Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multicenter, placebo-controlled clinical trial. Hide M, Suzuki T, Tanaka A, Aoki H. Allergol Int; 2019 Jan; 68(1):59-67. PubMed ID: 30029967 [Abstract] [Full Text] [Related]
19. Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain. Valero A, de la Torre F, Castillo JA, Rivas P, del Cuvillo A, Antépara I, Borja J, Donado E, Molà O, Izquierdo I. Drug Saf; 2009 Jan; 32(1):33-42. PubMed ID: 19132803 [Abstract] [Full Text] [Related]
20. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. Martínez-Cócera C, De Molina M, Martí-Guadaño E, Pola J, Conde J, Borja J, Pérez I, Arnaiz E, Izquierdo I, Spanish Rupatadine Rhinitis Study Group. J Investig Allergol Clin Immunol; 2005 Jan; 15(1):22-9. PubMed ID: 15864879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]